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ABSTRACT 
 The dihydroorotase (DHOase) domain of the 
multifunctional protein carbamoyl-phosphate 
synthetase 2, aspartate transcarbamoylase, and 
dihydroorotase (CAD) catalyzes the third step in 
the de novo biosynthesis of pyrimidine nucleotides 
in animals. The crystal structure of the DHOase 
domain of human CAD (huDHOase) revealed that, 
despite evolutionary divergence, its active site 
components are highly conserved with those in 
bacterial DHOases, encoded as monofunctional 
enzymes. An important element for catalysis, 
conserved from Escherichia coli to humans, is a 
flexible loop that closes as a lid over the active site. 
Here, we combined mutagenic, structural, 
biochemical, and molecular dynamics analyses to 
characterize the function of the flexible loop in the 
activity of CAD's DHOase domain. A huDHOase 
chimera bearing the E. coli DHOase flexible loop 
was inactive, suggesting the presence of distinctive 
elements in the flexible loop of huDHOase that 
cannot be replaced by the bacterial sequence. We 
pinpoint Phe-1563, a residue absolutely conserved 
at the tip of the flexible loop in CAD's DHOase 
domain, as a critical element for the conformational 
equilibrium between the two catalytic states of the 
protein. Substitutions of Phe-1563 with Ala, Leu or 
Thr prevented the closure of the flexible loop and 
inactivated the protein, whereas substitution with 
Tyr enhanced the interactions of the loop in the 
closed position and reduced fluctuations and the 
reaction rate. Our results confirm the importance of 
the flexible loop in CAD's DHOase domain and 
explain the key role of Phe-1563 in configuring the 
active site and in promoting substrate strain and 
catalysis.  
________________________________________ 
 
 Dihydroorotase (DHOase) (EC 3.5.2.3) is a 
ubiquitous Zn metalloenzyme that catalyzes the 
reversible condensation of carbamoyl aspartate 
(CA-asp) to dihydroorotate (DHO) in the third step 
of the de novo biosynthesis of pyrimidine 
nucleotides (1). Despite being present in all 
organisms, there is an intriguing number of 
different DHOase forms (2,3). Understanding the 
differences among DHOases, particularly in the 
layout of the active site, could lead to the 
development of improved inhibitors for treating 
microbial and parasitic infections or as 
antiinflammatory or antitumoral agents (4-8). 
 In animals, DHOase is fused with carbamoyl 
phosphate synthetase and aspartate 
transcarbamoylase (ATCase), the enzymes 
catalyzing the previous steps in the de novo 
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pathway, forming a single polypeptide of ~250 kDa 
named CAD that self-assembles into hexameric 
particles ((9,10); reviewed in (1,11)). Contrary, 
in bacteria, DHOases are encoded as separated 
proteins that function independently (bacterial type 
II DHOases; e.g. Escherichia coli) or in association 
with ATCase (bacterial type I; e.g. Aquifex 
aeolicus). The evolutionary advantages for the 
fusion of DHOase into the multienzymatic CAD 
protein, as well as the catalytic and regulatory 
mechanisms of such a large complex are yet to be 
uncovered. For this, detailed information about the 
structures of the individual enzymatic domains and 
about the architecture of CAD are needed.  
 Previously, we reported the crystal structure of 
the DHOase domain of human CAD (huDHOase) 
(2,12). huDHOase is a dimer with each subunit 
folding in a (b/a)8-barrel motif and holding an 
active site nucleated by two Zn2+ ions and shaped 
by the loops connecting the carboxy-edge of the 
central b-barrel with the outer a-helices (Fig. 1A). 
The structure proved that despite the existence of 
specific peripheral structural motifs and distinctive 
quaternary organizations, there is a high 
conservation of the active site elements between 
eukaryotic and prokaryotic DHOases  (2,13-15).  
 One important element that was proven to be 
conserved from E. coli to humans is a loop that 
fluctuates between a closed (loop-in) or open (loop-
out) position whether CA-asp or DHO are bound, 
respectively, to the active site (Fig. 1A,B) 
(2,16,17). This flexible loop reaches in towards the 
active site with CA-asp bound and is proposed to 
aid in catalysis by orienting and increasing the 
electrophilicity of the substrate, excluding water 
molecules and stabilizing the transition-state (16-
18). Then, upon formation of DHO, the loop moves 
away from the active site facilitating product 
release. As an exception, bacterial type I DHOases 
present a rigid and shorter loop that interacts 
minimally with the substrate (19) (Fig. 1C), and 
require the intimate association with ATCase to 
complete the active site and attain full activity (19-
21).  
 The flexible loop exhibits a two-amino acid 
signature that is characteristic for each DHOase 
type (2,15,18) (Fig. 1C). In all cases, the first 
residue is a Thr, namely Thr-109 in Escherichia 
coli DHOase (ecDHOase) or Thr-1562 in 
huDHOase, which interacts through its side chain 
with the b-COOH group of CA-asp (Fig. 1B-E). In 
E. coli and other bacterial type II DHOase the 
second specific residue is also a Thr (Thr-110 in 
ecDHOase) that occupies the tip of the loop and 
binds through its side chain to the a-COOH group 
of CA-asp (Fig. 1C,E). Mutating either of the two 
Thr inactivates ecDHOase, proving the importance 
of the loop in the reaction (16). In CAD, on the 
other hand, the flexible loop is two residues shorter 
than in ecDHOase and replaces the second Thr by a 
conserved Phe (Phe-1563 in huDHOase) (Fig. 
1C,D) (2). We previously demonstrated that 
mutations T1562A or F1563A impair the activity of 
huDHOase (2), proving that, as in ecDHOase, the 
flexible loop also plays a key functional role in 
CAD.  
 Now, we further interrogate how the flexible 
loop contributes to the activity of huDHOase. We 
report that a human DHOase chimera bearing the 
flexible loop of E. coli DHOase is inactive, 
suggesting that, despite having a conserved 
function, the flexible loops might have different 
functional and structural features. We also 
produced four different huDHOase variants, 
replacing Phe-1563 at the tip of the flexible loop 
with Ala, Thr, Leu or Tyr, measured the activities 
and determined their crystal structures. These 
results, combined with molecular dynamics 
simulations, highlight the key contribution of the 
Phe in configuring the active site of CAD's DHOase 
domain.  
 
Results 
A human DHOase chimera with the flexible loop 
of E. coli DHOase is inactive 
 To test the functional similarity between the 
flexible loops of human and E. coli DHOases, we 
replaced the loop of huDHOase 
(1559LNETFSELRLD1569) by the equivalent region 
in ecDHOase (105PANATTNSSHGVT117) (Fig. 
1C). We generated two huDHOase chimeras, one 
with the exact E. coli flexible loop (hereafter, 
mutant EFL-1) and another one that preserves 
residue Leu-1559 at the beginning of the loop 
(mutant EFL-2) in case a Pro could affect the 
movements of the hinge residues after strand b4 
(Figs. 1C and 2A,B). Both mutants were produced 
following a similar protocol as for huDHOase wild-
type (WT) (Supporting Fig. S1), although the lower 
yield suggested folding or solubility problems. 
Indeed, salt concentration in final size-exclusion 
chromatography (SEC) was increased (from 0.15 M 
to 0.25 M) to prevent protein precipitation.  
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 Analysis by SEC coupled to multi-angle light 
scattering (SEC-MALS) showed that the EFL 
mutants injected at 1.2 µM eluted in a main peak 
corresponding to a monomer, whereas the WT 
behaved as a dimer at this concentration (Fig. 
2A,B). At 6-12 µM, the mutants eluted in a broader 
peak of ~60 kDa, suggesting an equilibrium 
between monomer and dimer. By increasing the 
concentration to 100 µM, the EFL mutants eluted in 
a main peak of ~80 kDa, matching the values 
obtained for the WT dimer (12). Using 
sedimentation velocity analysis, we estimated that 
the Kd for the EFL-2 dimer is 1.1 ± 0.4 µM, (Fig. 
2C), whereas we failed to detect the dissociation of 
the WT dimers under similar conditions (2). These 
results indicate that the replacement of the flexible 
loop weakens the dimerization of huDHOase.       
 We determined the crystal structure of the 
mutant EFL-2 free of ligands and in complex with 
DHO or with the inhibitor fluoroorotic acid (FOA). 
Crystals grown in similar conditions as WT reached 
~0.1 mm in the maximum dimension and belonged 
to space group C2221 with unit cell dimensions a = 
82, b = 159, c = 61 Å (Table 1). The crystals 
diffracted X-rays to resolutions better than 1.8 Å 
using synchrotron radiation and the phases were 
determined by molecular replacement. As reported 
for WT (2), the crystals contain one protein subunit 
per asymmetric unit, with a VM of 2.35 Å Da-1, and 
a dimer is formed through a crystallographic 
twofold axis. The electron density is continuous and 
well-defined for the entire polypeptide chain except 
for the mutated loop that can be hardly seen in the 
structures with DHO or FOA, but that clearly 
adopts an open conformation in the apo structure 
(Fig. 2D,E). The rest of the EFL structure is 
virtually identical to the WT, including the Zn2+ 
ions and the bridging water at the active site. The 
DHO and FOA molecules occupy the position 
described for the WT, although they make an 
additional interaction with the side chain of Tyr-
1558 that adopts a different rotamer (Fig. 2D). 
Since we could not crystallize the mutant bound to 
CA-asp, it is unclear whether the E. coli flexible 
loop could reach a closed conformation on the 
huDHOase active site to favor the reaction (Fig. 
2E). 
 We characterized the activity of mutant EFL-1. 
The DHOase reaction is reversible and pH-
dependent (2,22,23), and thus, we measured the 
cyclization of CA-asp to DHO (or forward reaction) 
at the favored low pH (5.5), and the degradation of 
DHO (reverse reaction) in alkaline conditions (pH 
8). The activity of the mutant is strongly 
diminished, with turnover rates in the forward 
(kcatCA-asp= 1.7 ± 1.1 min-1) and reverse (kcatDHO= 5.9 
± 0.9 min-1) reactions that are 120- or 50-fold lower, 
respectively, compared to the WT (Fig. 3A,B). 
These results further support that the flexible loop 
of huDHOase is key for the reaction, and suggest 
that the E. coli flexible loop might not be 
compatible with the human enzyme. 
 
A distinctive phenylalanine in the flexible loop of 
CAD's DHOase domain is key for catalysis 
 We then focused on a distinctive feature of the 
DHOase domain of CAD: the Phe at the tip of the 
flexible loop.  We made three huDHOase mutants 
substituting Phe-1563 with Thr (mutant F1563T), 
Leu (F1563L) or Tyr (F1563Y). These variants and 
the previously reported F1563A mutant were 
produced as the WT (Supporting Fig. S1) and 
behaved as stable dimers in solution (data not 
shown).  
 Mutants F1563A, F1563T and F1563L showed 
a decreased rate in the forward reaction of 4-8% of 
the WT, whereas the activity in the reverse reaction 
is ~1 % (Fig. 3A,B). In turn, mutation F1563Y 
causes a milder effect with activities that are 44 % 
and 72 % in the forward and reverse reactions, 
respectively, compared to WT. The four mutants 
show a KMCA-asp similar to WT and although the low 
activity did not allow to measure the KMDHO of 
mutants F1563A/T/L, the KMDHO of mutant F1563Y 
was also similar to WT (Fig. 3C,D). These results 
indicate that the reduced catalytic efficiency is not 
an effect of substrate concentration (KM) but rather 
a decrease in kcat due to the substitution of the 
conserved Phe in the flexible loop.  
 It is noteworthy that the different Phe-1563 
mutations do not affect the forward and reverse 
reactions in an equal manner. As reported for WT  
(2), mutant F1563Y is more efficient catalyzing the 
forward than the reverse reaction at their optimum 
pHs, although both rates equilibrate near neutral pH 
(Fig. 3A). By contrast, mutants F1563A, F1563T 
and F1563L show a more detrimental effect in the 
reverse than in the forward reaction, although as 
before, the effect on both rates is comparable at pH 
7.  
  
Structural characterization of huDHOase Phe-
1563 mutants 
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 To understand the impact of the mutations on the 
function of the flexible loop, we determined the 
structures of the Phe-1563 mutants crystallized in 
the absence or presence of CA-asp at different pHs. 
Well-diffracting crystals of the four mutants grew 
in similar conditions and presented the same space 
group and unit cell as the WT and EFL-2 mutant 
(Tables 1 and 2 and Supporting Table S1). The 
electron density was continuous and well-defined 
for the entire polypeptide chain (Fig. 4A-D and 
Supporting Fig. S3), allowing the building and 
refinement of the models to correct geometry and 
reasonable R and Rfree values (Tables 1 and 2 and 
Supporting Table S1). 
 The overall structures of the mutants are 
virtually identical to the WT, yielding RMSD 
values <0.11 Å for the superposition of the 
complete protein but excluding the flexible loop 
(Supporting Fig. S2). In the apo-form, the mutants 
show the flexible loop in open conformation (Fig. 
4E-H) and the active site filled with solvent and 
with a formate molecule from the crystallization 
solution that mimics the interactions of the a-
COOH group of CA-asp or DHO with the side 
chains of residues Asn-1505, Arg-1475 and His-
1690 (Supporting Fig. S3) (2). 
 The structures of mutants F1563A, F1563T and 
F1563L co-crystallized with CA-asp at different pH 
values (6.5, 7.0 and 7.5; Table 2 and Supporting 
Table S1) showed a molecule of DHO bound in the 
active site with full-occupancy, and accordingly, 
present the flexible loop in the open conformation 
(Fig. 4A-C, E-G). The flexible loop is not involved 
in lattice contacts, and thus, we exclude that the 
loop-out conformation could be favored by crystal 
packing. In contrast, the structure of mutant 
F1563Y co-crystallized with CA-asp (at pH 6.5, 7.0 
or 7.5) exhibited a molecule of this ligand within 
the active site (Fig. 4D,H), the flexible loop in the 
closed conformation and the side chain of Thr-1562 
interacting with the b-COOH group of CA-asp (Fig. 
5A). The mutated Tyr occupies virtually the same 
position as Phe-1563 in the WT and makes a H-
bond through the carbonyl oxygen with the side 
chain of Asn-1505 and van der Waals contacts with 
the a-COOH group of CA-asp and with residues 
His-1690, Arg-1475, Pro-1701 and Pro-1702 (Fig. 
5A,C). As observed in the WT, the aromatic ring of 
the mutated Tyr falls on top of the side chain of His-
1690 and favors cation-pi interactions with the side 
chains of residues Arg-1475 and Arg-1507. In 
addition, the phenolic oxygen of Tyr allows two 
extra H-bonds with the side chain of Arg-1507 and 
with an ordered water molecule.  
 However, the position of the mutated Tyr is 
different from the position of Phe-1563 in the WT 
apo structures (Fig. 5B,D). In the open 
conformation, the side chain of Phe-1563 is in close 
proximity to the b2-a2 loop, making a planar 
stacking interaction with the side chain of Arg-1507 
(Fig. 5D). In this position, the phenolic oxygen of 
the mutated Tyr would clash with the carbonyl O of 
Asn-1505 and thus, the side chain is oriented in an 
opposite direction (Fig. 5B). This readjustment of 
the flexible loop correlates with a partial disorder in 
the side chain of Tyr-1558 that adopts two alternate 
conformations, one as in the WT and the other 
pointing towards the substrate, as seen in the EFL-
2 mutant (Figs. 2E and 5B). 
 The structural comparison between the mutants 
and the WT did not reveal other significant 
differences in the orientation of the substrates, the 
position of the catalytic residues or the coordination 
of the Zn2+ ions at the active site. Thus, we conclude 
that the nature of the residue occupying the position 
of Phe-1563 affects the conformation of the flexible 
loop and is responsible for the differences in 
activity and for the exclusive binding of CA-asp or 
DHO to the active site of the protein in the crystal. 
 
Simulation of the loop fluctuation by molecular 
dynamics 
 We further interrogated the role of Phe-1563 by 
comparing the movements of the loop in the WT 
and F1563A mutant using molecular dynamics 
(MD). The simulations started with both proteins 
having DHO in the active site and the flexible loop 
in open conformation. Interestingly, the loop in the 
WT is able to sample closed conformations. 
Contrary, the mutated loop does not reach 
conformations compatible with the closed state, 
remaining highly flexible and quite far from the 
active site. The analysis of the distances between 
the loop and the DHO quantitatively shows such 
differences between the two protein conformational 
behaviors (Fig. 6A). In the WT, the mode of the 
distribution (i.e. the most probable value) of the 
distance between the Ca of residue 1563 and DHO 
is ~5 Å, corresponding to the closed or near closed 
state, and presents a second minor peak at 10 Å that 
corresponds to the open conformation. In turn, 
mutant F1563A shows a distribution centered at 10 
Å, indicating that during the simulation, the 
mutated loop did not reach the closed state. The 
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analysis of the fluctuations shows a different 
behavior for the dynamics of the loop, being the 
fluctuations more pronounced in the mutated 
system (Fig. 6B). This is explained by the WT loop 
which, early in the simulation, becomes stabilized 
in a closed state, thus reducing its fluctuations.  
 
Discussion 
Unique features in the flexible loop of CAD's 
DHOase domain 
 Despite evolutionary divergence, the structure 
of huDHOase revealed a striking similarity with the 
active site of ecDHOase (2). Not only the catalytic 
elements occupy virtually identical positions in 
both enzymes, but also no significant changes were 
observed whether the active sites are free or bound 
to the substrates or to specific inhibitors. This 
preservation and rigidity of the active site is only 
broken by the flexible loop and its lid movement, 
which appears tightly coupled to the catalytic state 
of the enzyme (Fig. 1D,E) (2,17). The flexible loop 
in the DHOase domain of CAD only shares one Thr 
with the equivalent loop of E. coli and other 
bacterial type II DHOases (human Thr-1562; E. coli 
Thr-109) (Fig. 1C). Nevertheless, upon CA-asp 
binding and lid closure, the invariant Thr takes the 
same position and interacts in the same manner with 
the substrate both in the human and E. coli proteins 
(2,16). Considering the similar arrangement of the 
catalytic elements, we found intriguing that the 
activity of huDHOase is ~50-fold lower than the E. 
coli enzyme (2,16). This difference could be due to 
small unnoticed movements (<1 Å) in the active site 
elements that affect catalysis (24), but also to 
different interactions of the flexible loop with the 
substrate and to the dynamics of the flexible loop 
itself.  
 In ecDHOase, a Thr (Thr-110) occupying the tip 
of the flexible loop makes an extra H-bond with 
CA-asp, whereas in CAD, the Phe at this position 
(Phe-1563) cannot make a similar interaction with 
the substrate (Fig. 1C-E). Interestingly, the 
damaging effect of mutation T110A makes the 
activity of ecDHOase more similar to that of the 
human enzyme (16).  To test whether an 
additional H-bond with CA-asp would increase the 
activity of huDHOase, we replaced the flexible loop 
of huDHOase by the equivalent sequence in the E. 
coli enzyme. However, rather than enhancing the 
reaction, the EFL chimera turned to be inactive 
(Fig. 3A,B). This bold mutation also destabilizes 
the formation of the dimers (Fig. 2A-C), indicating 
that the contribution of the residues at the hinge of 
the flexible loop (Leu-1559, Asn-1560 and Asp-
1569) to the intersubunit contacts might be more 
relevant than initially thought (2) (Fig. 1C).  
 This result also stresses an interesting difference 
with ecDHOase. In the bacterial enzyme, 
dimerization occurs by interactions of the loops 
adjoining the flexible loop above the b-barrel, 
rather than by lateral contacts as in huDHOase 
(2,14,17) (Supporting Fig. S4). Moreover, 
ecDHOase shows a strong cooperativity between 
the two active sites (17), consistent with an 
asymmetry in the crystal structures, with one 
subunit having CA-asp bound at the active site and 
the other DHO (14,17). Indeed, it has been 
proposed that the binding of CA-asp or DHO and 
the accompanying movement of the flexible loop 
could correlate with changes in dimerization 
interface of ecDHOase, allowing the 
communication between subunits (17). Contrary in 
huDHOase, we have not detected cooperativity, and 
the binding of CA-asp or DHO to one subunit does 
not appear to condition the active site content in the 
other subunit (2). Perhaps the two additional 
residues in the ecDHOase flexible loop and the 
larger amplitude of its movement compared to 
huDHOase (Figure 1D,E) could be required for the 
interaction with the dimerization elements. 
 Swapping the entire flexible loop must distort 
the dimerization interface of huDHOase and this 
could explain at least part of the detrimental effect 
on the activity. Indeed, monomeric huDHOase 
mutants were reported to be 2-fold less active than 
WT (2). However, the negligible activity of the 
protein chimera likely responds to a lack of 
complementarity between the E. coli loop and the 
huDHOase active site. Although, we initially 
thought that perhaps a shorter or longer E. coli 
sequence could allow the closure and precise 
positioning of the loop for catalysis, the following 
experiment proved that this might not be the case. 
We demonstrated that the single substitution of 
Phe-1563 with the Thr present in E. coli and all 
bacterial type II DHOases is sufficient to damage 
huDHOase activity (Fig. 3A,B). This result 
suggests that the importance of the residue at the tip 
of the flexible loop goes beyond its ability to form 
a H-bond with the substrate. Indeed, it is reported 
that in ecDHOase, substitution of Thr-110 with Val 
only decreases the activity to 80%, whereas 
substitution with Ser, which retains the H-bond 
with CA-asp, has a more damaging effect, 
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decreasing the activity to 33% (16). Overall, these 
data support the view that there must exist a 
complementarity between the residue at the tip of 
the flexible loop and other active site elements. In 
fact, we prove that Phe-1563 can be replaced by a 
Tyr with only mild effects on the activity of 
huDHOase (Fig. 3), but not by a Leu, indicating that 
the aromatic ring at the side chain and not only its 
hydrophobic character is important for correct 
functioning of the loop. This result brings the 
attention to the relevance of the cation-pi 
interactions between Phe-1563 and Arg-1475 and 
Arg-1507 for the stabilization of the loop in the 
closed conformation, and to the planar stacking 
interaction of Phe-1563 with Arg-1507 in the open 
state (Fig. 5), which went unnoticed in previous 
structural work (2). 
 Altogether, our results confirm the key 
participation of the flexible loop in the activity of 
CAD's DHOase domain, and prove that despite 
sharing a conserved catalytic role, the flexible loop 
stands as the most dissimilar active site element, 
being characteristic and likely irreplaceable for 
each DHOase group.  
 
Phe-1563 is a secure grip that stabilizes the 
closure of the flexible loop 
 Given the reversibility of the DHOase reaction, 
we expected that, similarly to what occurred with 
the WT, the crystal structures of the Phe-1563 
mutants would present an average electron density 
in the active site corresponding to a mixture of CA-
asp and DHO and to the flexible loop in the two 
alternate conformations (2). Thus, we found 
surprising that the structures of mutants 
F1563A/T/L had the loop open and DHO bound 
with full occupancy in the active site, whereas 
mutant F1563Y crystallized exclusively with the 
loop closed and with CA-asp (Fig. 4A–D). These 
structures strongly suggest that the interactions of 
Phe-1563 are key for the conformational 
equilibrium between the two catalytic states of the 
protein. The MD data support this hypothesis, 
showing that without the Phe, the flexible loop is 
not stabilized over the substrate and remains in an 
open conformation during the simulation (Fig. 6A). 
Our data further prove that the lack of closure is not 
an impediment for proper binding of DHO, as 
shown by the nearly identical position occupied by 
this substrate in the structures of the F1563A/T/L 
mutants (Fig. 4A-C). This would explain that, 
despite the low activity, the DHO produced during 
the crystallization binds preferentially to the open 
active site of the F1563A/T/L mutants. On the other 
hand, since Tyr mimics the hydrophobic and cation-
pi interactions of Phe-1563 (Fig. 5), we postulate 
that mutant F1563Y must have a similar tendency 
to reach the closed state as the WT (Fig. 6), and that 
the additional interactions of the phenolic oxygen 
may increase the stability of the loop-in 
conformation, favoring that the crystals show 
exclusively this active site arrangement (Figs. 4D 
and 5A). Since no other differences have been 
observed between the structures of the mutants free 
or bound to the substrate and the WT protein, we 
conclude that the lack of closure (mutants 
F1563A/T/L) or the additional stabilization in the 
closed state (mutant F1563Y) hamper the dynamic 
fluctuations of the flexible loop in and out the active 
site and that this causes the diminished activity of 
the mutants. 
 The observation that WT and mutant F1563Y 
show a faster rate in the reverse than in the forward 
reaction (measured at their respective optimum 
pHs), whereas mutations F1563A/T/L show an 
opposite trend (Fig. 3A,B) leads on to further 
question how the grip of the Phe aids during 
catalysis. According to the proposed catalytic 
mechanism (14,16-18), the biosynthesis of DHO 
starts by removal of the water molecule bridging the 
two Zn2+ ions to allow binding of CA-asp, and this 
induces the closure of the flexible loop. Based on 
the present data, we propose that the interaction 
between the side chain of Thr-1562 and the b-
COOH of CA-asp is not sufficient to stabilize the 
loop-in conformation, and that the anchoring of 
Phe-1563 is mandatory to confine the substrate at 
the active site in order to enhance the nucleophilic 
attack of the N atom to the b-COOH group and to 
stabilize the transition-state of the reaction (Fig. 
1B). Then, upon cyclization, the b-COOH group is 
converted to a carbonyl group and to a hydroxide 
ion that remains bound to the Zn2+ ions (Fig. 1B), 
whereas the DHO moves away from the metals, 
causing a steric pressure on residue Thr-1562 and 
"pushing" the flexible loop to the open 
conformation, to allow product release and the 
beginning of a new reaction cycle (17,18). Thus, 
our findings suggest that mutations affecting the 
closure of the flexible loop can be detrimental either 
because they impair the interactions and decrease 
the frequency with which the loop reaches the 
stable closed conformation (EFL and F1563A/T/L 
mutants), or because they provide a stronger grip 
that counteracts the "pushing" of the DHO and 
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hinders the opening and release of the product 
(F1563Y). 
 In the reverse reaction, the degradation of DHO 
involves the deprotonation of the water molecule 
bridging the metal ions and further nucleophilic 
attack on the DHO ring (Fig. 1B), following the 
same mechanistic steps as before but in opposite 
order. As seen in the structures of the F1563A/T/L 
and EFL mutants, DHO enters in the active site and 
does not require the interaction with the flexible 
loop for correct binding. Then, the loop must close 
over the active site, as observed in the MD 
simulations of the WT, and "push" the DHO ring 
into close proximity to the bridging water to favor 
the nucleophilic attack. In this case, there is no 
interaction between Thr-1562 and –the missing b-
COOH group of– DHO, and thus, Phe-1563 must 
play a key role in promoting the closure of the loop 
and in introducing steric strain between the DHO 
and the attacking water. The negligible rate of the 
F1563A/T/L mutants in the reverse reaction likely 
reflects the failure of the flexible loop to compress 
the substrates and highlights the prominent role of 
Phe-1563 in configuring the active site of CAD's 
DHOase domain and in promoting catalysis. 
 This study highlights an important difference 
between human and bacterial DHOases and lends 
further insight for the future development of 
inhibitory compounds that –mimicking the effect of 
the mutations reported here–  could block the 
closure or opening of the flexible loop. 
 
Experimental procedures 
Site-directed mutagenesis  
 Mutagenesis was carried out by primer 
extension, incorporating mutagenic primers in 
independent nested PCRs before combining them 
in the final product in a second round of PCR using 
specific flanking primers (25). The primer 
sequences are detailed in Supporting Table S2. The 
cDNA of human CAD (UniProt P27708) purchased 
from Open Biosystems (clone ID 5551082) was 
used as the template for the mutagenesis. Gene 
amplification was carried out with Phusion High-
Fidelity DNA Polymerase (New England Biolabs). 
The amplified mutated genes were inserted into the 
pOPIN-M expression vector (Oxford Protein 
Production Facility) using In-Fusion technology 
(Clontech). This vector tags the N-terminus of the 
protein with a His6-tagged maltose-binding protein 
(His6-MBP) followed by a specific cleavage site for 
protease PreScission. The resulting plasmids with 
desired gene mutations were verified by 
sequencing. Mutant EFL-1 was generated by four 
successive rounds of mutagenesis using the pairs of 
primers listed in Supporting Table S2. Mutant EFL-
2 was generated from the EFL-1 reverting the 
mutation L1559P back to Leu. 
 
Protein production 
 Mutated forms of huDHOase were expressed 
and purified as previously reported (2,12). The 
proteins were produced in HEK293S-GnTI cells 
adapted to suspension culture in FreeStyle medium 
(Invitrogen) with 1% fetal bovine serum and grown 
in an orbital stirrer at 135 rpm under standard 
humidified conditions (26). The cultures (1.5 
million cells/ml) were transfected with the pOPIN-
M vectors carrying the mutated huDHOase genes in 
a 1:3 ratio mixture of DNA (1 mg/ml) and 
polyethylenimine (PEI 25 kDa branched; Sigma). 
Prior to the transfection, DNA and PEI were diluted 
to 20 and 60 mg/ml, respectively, in UltraDOMA 
medium (Lonza) and incubated separately for 5 min 
at room temperature. Then, the solutions were 
mixed and incubated 10 min before adding the 
mixture to the cells, which were harvested after 2–
3 days and stored at -80 ºC. For purification, the 
cells were thawed and resuspended in buffer A (20 
mM Tris–HCl pH 8, 0.5 M NaCl, 10 mM 
imidazole, 5% glycerol, 2 mM b-mercaptoethanol) 
with 2 mM phenylmethanesulfonyl fluoride 
(PMSF) and were disrupted in a douncer followed 
by brief sonication. The clarified lysate was applied 
onto a 5 ml Ni2+-loaded HisTrap Chelating FF 
column (GE Healthcare, USA). Following 
extensive washing with buffer A containing 25 mM 
imidazole, the protein was eluted with buffer A 
supplemented with 250 mM imidazole. Excess 
imidazole was removed by overnight dialysis 
against the same solution containing 30 mM 
imidazole with the inclusion of GST-tagged 
PreScission protease (1/20th of the protein weight) 
within the dialysis bag to cleave off the His6-MBP 
tag. Then, the sample was re-loaded onto a HisTrap 
column connected to a 5 ml GSTrap FF column 
(GE Healthcare, USA) to retain the non-cleaved 
protein, the His6-MBP tag and the GST-tagged 
protease. The untagged huDHOase found in the 
columns flowthrough was concentrated to 3 mg ml-
1 using an Amicon Ultra system with a 10 kDa 
cutoff membrane and further purified by SEC on a 
Superdex 200 10/300 column (GE Healthcare, 
USA) equilibrated with GF buffer (20 mM Tris pH 
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8, 0.15 M NaCl, 20 µM ZnSO4, 0.2 mM TCEP). For 
the EFL mutants, the NaCl concentration in the GF 
buffer was increased to 0.25 M. The mutated 
proteins eluted as single peaks that were pooled and 
concentrated as before to 3 mg ml-1 and used 
directly for crystallization studies. The excess 
protein was supplemented with 20% glycerol, 
flash-frozen in liquid nitrogen before SEC and 
stored at 193 K for several weeks. Freezing did not 
have a noticeably effect neither in the 
crystallization nor in the specific activity. All 
purification steps were carried out at 277 K. Protein 
concentration was determined from the absorbance 
at 280 nm using a theoretical extinction coefficient 
of 38,960 M-1 cm-1.  
  
Crystallization, data collection and structure 
determination 
 Crystals of the EFL and Phe-1563 mutants, 
alone or in the presence of 4 mM DHO, CA-asp or 
FOA were obtained as previously reported for the 
WT (2,12). Optimal crystallization conditions were 
similar for all the mutants and consisted of 2–3 mg 
ml-1 protein in GF buffer and 2.5–3 M sodium 
formate and 0.1 M HEPES pH 6.5-7.5 as the mother 
liquor. Prior to flash-freezing, the crystals were 
transferred to cryoprotectant solutions containing 
increasing amounts of glycerol, up to a final 
concentration of 15 %, and 20 µM ZnSO4. For the 
crystals grown in presence of ligands, the 
compound was also added to the cryoprotectant 
solutions at a final concentration of 4 mM. X-ray 
diffraction datasets were collected at PETRA-III 
(DESY, Hamburg), XALOC (ALBA, Barcelona) 
or ID23-1 (ESRF, Grenoble) using Pilatus 6M 
detectors. Data processing and scaling were 
performed with XDS (27) and autoPROC (28). 
Crystallographic phases were obtained by 
molecular replacement using PHASER (29) and the 
structure of huDHOase WT [PDB entries 4C6C 
(apo) and 4C6I (DHO-bound)) as the search 
models. The models were constructed by iterative 
cycles of model building in COOT (30) and 
refinement in PHENIX (31) or Refmac5 in CCP4 
(32,33). 
 
Enzymatic assays  
 DHOase activity was assayed 
spectrophotometrically following the production or 
degradation of DHO by absorbance at 230 nm as 
detailed in (2). Reactions were carried out at 25 ºC 
in a final volume of 100 µl containing 50 mM 
sodium phosphate (at pH 5.5, 7 or 8), 150 mM 
NaCl, 20 µM ZnSO4, 0.1 mg/ml of bovine serum 
albumin and 0.5 mM DHO or 5 mM CA-asp. 
Protein concentrations were 0.25 µM for the wild-
type and 2.5-3 µM for the mutants. Kinetic data 
analysis was performed with GraphPad Prism. 
 
Size exclusion chromatography and multi-angle 
light-scattering (SEC-MALS)  
 400 µl of purified protein at different 
concentrations (WT, 1.2 µM; EFL-1, 120, 12 and 
1.2 µM; EFL-2: 93, 6 and 1.2 µM) was fractionated 
on a Superdex 200 10/300 column equilibrated in 
GF buffer using an AKTA purifier (GE-Healthcare, 
USA). The eluted samples were characterized by 
in-line measurement of the refractive index and 
multi-angle light scattering using Optilab T-rEX 
and DAWN 8+ instruments, respectively (Wyatt 
Technology). Data were analyzed with ASTRA 6 
software (34) and plotted with GraphPad. 
 
Analytical Centrifugation 
 Sedimentation velocity studies were performed 
using a Beckman XL-I centrifuge, an An-50Ti 
rotor, and a 12-m double-sector centerpiece. The 
absorbance at 230 nm was measured in order to 
follow the distribution of the sedimenting 
molecules at 42,000 rpm and 293 K. Sedimentation 
coefficient distributions were calculated using 
SEDFIT 15.01b (35). Purified EFL-2 mutant 
samples were in GF buffer at concentrations 14, 
9.3, 4.6, 2.3, 1.2 and 0.6 µM. 
 
Molecular dynamics  
 Molecular dynamics (MD) simulations of the 
WT and F1563A proteins were performed using the 
corresponding X-ray structures as starting models. 
The simulations started with both proteins having 
DHO in the active site and the flexible loop in open 
conformation. MD simulations, in the NVT 
ensemble (constant temperature and volume), with 
fixed bond lengths and a time step of 2 fs for 
numerical integration were performed with the 
GROMACS software package (36). The GROMOS 
force field (37) has been used for the proteins, 
whereas the DHO molecule has been modelled by 
means of the ATB server (38). Water was modeled 
by the simple point charge (SPC) model. A 
nonbond pairlist cutoff of 9.0 Å was used, and the 
pairlist was updated every four time steps. The 
long-range electrostatic interactions were treated 
with the particle mesh Ewald method (39). The v-
rescale temperature coupling (40) was used to keep 
the temperature constant at 300 K. The proteins 
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were solvated with water and placed in a periodic 
truncated octahedron large enough to contain the 
proteins and 1.0 nm of solvent on all sides. 
Counterions were added by replacing a 
corresponding number of water molecules to 
achieve a neutral condition. The side chains were 
protonated as to reproduce a pH of about 7. 
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T
able 2. D
ata collection and refinem
ent statistics for structures w
ith C
A
-asp/D
H
O
 at pH
 7.0. 
 
E
FL
-2 
F1563A
 
F1563T
 
F1563L
 
F1563Y
 
PD
B
 code 
6H
G
3 
6H
FH
 
6H
FP 
6H
FL 
6H
FR
 
D
ata collection 
 
 
 
 
 
B
eam
line 
ID
23-1, ESR
F 
PETR
A
 III- D
ESY
 
PETR
A
 III- D
ESY
 
PETR
A
 III- D
ESY
 
PETR
A
 III- D
ESY
 
W
avelength (Å
) 
1.0 
1.0 
1.0 
1.0 
1.0 
Space group 
C
222
1  
C
222
1  
C
222
1  
C
222
1  
C
222
1  
U
nit cell, a,b,c (Å
)  
81.9, 159.5, 61.9 
82.0, 159.1, 61.6 
82.1, 159.0, 61.2 
82.0, 158.8, 61.2 
81.9, 159.1, 61.0 
R
esolution (Å
) 
48.88 - 1.97 
(2.04 - 1.97) 
36.45 - 1.45 
(1.50- 1.45) 
46.89 - 1.20 
(1.24- 1.20) 
40.97 - 1.35 
(1.40 - 1.35) 
46.75 - 1.30 
(1.35 - 1.30) 
R
eflections  
(observed/unique) 
188,663 / 28,867 
(19,918 / 2,883) 
468,465 / 71,360 
(40,311 / 6,886) 
800,184 / 124,981 
(75,046 / 12,167) 
564,836 / 87,621 
(53,868 / 8,637) 
641,051 / 97,702 
(56,548 / 9,576) 
M
ultiplicity 
6.5 (6.9) 
6.6 (5.9) 
6.4 (6.2) 
6.4 (6.2) 
6.6 (5.9) 
R
m
eas (%
) 
6.2 (45.6) 
7.3 (75.8) 
4.6 (67.0) 
4.6 (68.5) 
4.4 (62.2) 
I/s
I  
19.4 (3.7) 
16.9 (2.4) 
21.6 (2.6) 
22.3 (2.4) 
21.9 (2.6) 
C
om
pleteness (%
) 
98.3 (99.6) 
99.4 (97.0) 
99.6 (97.8) 
99.8 (99.5) 
99.7 (99.2) 
C
C
1/2  
99.9 (92.5) 
99.9 (82.7) 
99.9 (87.0) 
1.0 (81.9) 
99.9 (89.4) 
W
ilson B
 factor (Å
2) 
30.50 
14.0 
13.2 
15.4 
15.9 
R
efinem
ent  
 
 
 
 
 
R
esolution (Å
) 
48.88 - 1.97 
36.45 - 1.45 
46.89 - 1.20 
40.97 - 1.35 
46.75 - 1.30 
N
o. reflections 
28,661 
71,346 
124,950 
87,611 
97,685 
R
-factor/R
free  (%
) 
16.12 / 17.79 
11.81 / 14.26 
12.20 / 13.69 
11.85 / 13.63 
12.64 / 14.40 
R
.m
.s. deviations 
   B
ond lengths (Å
) 
   B
ond angles (°)  
 0.007 
1.32 
 0.008 
1.00 
 0.011 
1.190 
 0.011 
1.120 
 0.01 
1.09 
N
o. atom
s (no H
) 
Protein + ligand  
W
ater 
 2,842 
293 
 2,911 
429 
 2,941 
513 
 2,901 
422 
 2,940 
364 
R
am
achandran plot  
Favored (%
) 
A
llow
ed (%
) 
O
utliers (%
) 
 96.61 
3.11 
0.28 
 95.53 
3.91 
0.56 
 96.08 
3.36 
0.56 
 95.80 
3.64 
0.56 
 95.80 
3.64 
0.56 
V
alues in parentheses are for the outerm
ost resolution shell. 
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Figure 1. (A) Crystal structure of huDHOase bound to DHO (PDB 4C6I). The central b-barrel is shown 
in red and Zn2+ ions as cyan spheres. The flexible loop is represented in the closed (yellow) and open 
(cyan) conformations. (B) Ball-and-stick representation of the reversible reaction, showing the position 
of the Zn2+ ions, the attacking water (wat) and the flexible loop. Red arrows indicate a nucleophilic 
attack. (C) Sequence alignment of the flexible loop region in the DHOases from E. coli (ec; bacterial 
type II), human (hu; domain within multi-functional CAD) and Aquifex aeolicus (ae; bacterial type I). 
Residues are colored according to the secondary structure, which is shown above the alignment. 
Residues in bold are highly conserved (≥90% identity) within their respective groups. Distinctive 
signatures are highlighted in brown background and huDHOase residues that change their accessibility 
upon dimerization are shown in grey background. Hinge residues are indicated by a purple box. (D, E) 
Comparison of the open and closed conformations of the flexible loop in human (D) and E. coli (E) 
DHOases. Active site is represented in semitransparent surface with Zn2+ ions as cyan spheres. Dashed 
lines represent hydrogen bonds. 
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Figure 2. SEC-MALS analysis of EFL-1 (A) and EFL-2 (B) mutants. The mutated region is shown 
above the graphs and is colored as in Fig. 1C. The different residue at the beginning of the loop is shown 
in cyan background. The elution profiles and molecular weight measurements of the mutants are shown 
in black, grey and light grey, corresponding to decreasing protein concentrations, whereas WT is shown 
in green. (C) Sedimentation velocity experiment of EFL-2. (D) Cartoon representation of the active site 
of mutant EFL-2 bound to DHO. The Zn2+ atoms and the bridging water are shown as cyan and red 
spheres, respectively. Dashed lines represent electrostatic interactions. The flexible loop is colored in 
yellow, and non-traceable regions are indicated with a thick dashed line. (E) EFL-2 apo structure. The 
loop of huDHOase WT in closed conformation and the side chain of Phe-1563 are shown in orange as 
a reference. A black arrow indicates the movement that the loop should undergo to reach the closed 
state. 
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Figure 3. (A) Activities of huDHOase WT and mutants in the forward (blue dots) and reverse reactions 
(pink dots) measured at pH 5.5 and pH 8, respectively. Activities at pH 7 are overlaid in lighter colors. 
(B) Zoom view of less active mutants. (C,D) Activities at increasing substrate concentrations in the 
forward (C) or reverse (D) reactions. Data were fitted to a Michaelis-Menten equation. Values are 
represented as mean ± standard deviation. 
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Figure 4. (A-D) Active sites in the crystal structures of mutants F1563A (A), F1563T (B), F1563L (C) 
and F1563Y (D) with 2Fobs-Fcalc electron density map. A molecule of DHO (A-C) or CA-asp (D) is 
shown with carbon atoms in magenta. Water molecules and Zn2+ ions are represented as red and light 
cyan spheres, respectively. (E-H) Views of the active site with superposition of the apo (cyan) and 
ligand-bound (yellow) structures.  
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Figure 5. Cartoon representation of the active site of huDHOase F1563Y bound to CA-asp (A) or in 
apo form (B). The flexible loop is colored with C atoms in yellow. Other residues in the active site are 
colored with C atoms in light blue. CA-asp is colored with C atoms in pink. (C,D) WT structures bound 
to CA-asp (C) or to FOA (D) with the flexible loop shown in orange. 
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Figure 6. (A) Distributions of distances between the Ca of residue 1563 and DHO for the WT (red 
lines) and F1563A mutant (black lines), as obtained by the corresponding MD simulations.  (B) RMSF 
for WT (red lines) and F1563A mutant (black lines) as obtained by the corresponding MD simulations. 
The area highlighted in yellow corresponds to the region of the flexible loop. 
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